Norris Biomedical Services Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Norris Biomedical Services General Information

Description

Developer of a financial consulting platform designed to arrange funding for small and medium biomedical organizations. The company's platform provides strategic support and also offers a range of services to new investors and existing stakeholders, enabling clients to get the required funds in the required time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Financial Software
Primary Office
  • Blackthorn House, Skull House Lane
  • Appley Bridge, Wigan
  • Lancashire WN6 9DB
  • England, United Kingdom
+44 01257 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Norris Biomedical Services Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Dec-2013 Completed Generating Revenue
To view Norris Biomedical Services’s complete valuation and funding history, request access »

Norris Biomedical Services Executive Team (3)

Name Title Board Seat Contact Info
Michael Norris Founder, Chief Executive Officer & Board Member
Neil Harrison Director, Corporate Finance
To view Norris Biomedical Services’s complete executive team members history, request access »

Norris Biomedical Services Board Members (1)

Name Representing Role Since
Michael Norris Norris Biomedical Services Founder, Chief Executive Officer & Board Member 000 0000
To view Norris Biomedical Services’s complete board members history, request access »

Norris Biomedical Services Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Spark Impact Corporate Venture Capital Minority 000 0000 000000 0
To view Norris Biomedical Services’s complete investors history, request access »